Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
AXSM
AXSM News & Events
-
Add to Watchlist
Trade AXSM
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
AXSM News
Healthcare Transformation: The Rise of Data-Driven Models
3d ago
Fool
Tempus AI and Others Poised to Transform Precision Medicine
3d ago
NASDAQ.COM
Potential Analysis of Small Biotech Stocks
6d ago
Fool
Axsome Therapeutics Q1 2026 Earnings Call Highlights
May 04 2026
seekingalpha
Axsome Therapeutics Shares Surge on FDA Approval and Strong Pipeline
May 04 2026
Fool
Amazon Launches Supply Chain Services, Pressuring Logistics Stocks
May 04 2026
CNBC
AXSOME THERAPEUTICS STOCK JUMPS 10.7% FOLLOWING INCREASED Q1 REVENUE
May 04 2026
moomoo
Axsome Therapeutics Q1 Sales Exceed Expectations
May 04 2026
stocktwits
Show More News
AXSM Events
No data
AXSM Monitor News
FDA Approves Axsome's Auvelity for Alzheimer's Agitation
May 04 2026
Axsome's AUVELITY Receives FDA Approval for Alzheimer's Agitation
Apr 30 2026
Axsome Therapeutics faces competition amid FDA review risk for Summit's ivonescimab
Mar 27 2026
Axsome Therapeutics Reports Strong Q4 Earnings Amid Market Decline
Feb 23 2026
Axsome Therapeutics projects strong revenue growth and FDA expansion for Auvelity
Jan 20 2026
Axsome Therapeutics projects $638.5M revenue for 2025, driven by AUVELITY sales
Jan 12 2026
Axsome Therapeutics receives FDA Priority Review for AXS-05
Dec 31 2025
AXSM Earnings Analysis
Axsome Therapeutics Inc Reports Third Quarter 2024 Financial Results
1 years ago
People Also Watch
